Role of D1 and D2 dopamine receptors in the discriminative stimulus properties of the atypical antipsychotic clozapine in rats

Drug Development Research

Volumn 46, Issue 2, 1999, Pages 139-147

  Porter, Joseph H ^a   Villanueva, Heidi F ^a   Rosecrans, John A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Atypical antipsychotics; Clozapine; Drug discrimination; Haloperidol; SCH 23390; Schizophrenia; Thioridazine

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BUTYROPHENONE DERIVATIVE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; THIORIDAZINE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; NONHUMAN; RAT; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; SCHIZOPHRENIA;

EID: 0032890760     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199902)46:2<139::AID-DDR7>3.0.CO;2-S     Document Type: Article

References (48)

1. 2 receptors: an autoradiographic analysis in rat brain. Brain Res Bull 16:517-525.
2. Arnt J, Skarsfeldt T. 1998. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18:63-101.
3. Boschmans SA, Perkin MF, Terblanche SE. 1987. Antidepressant drugs: imipramine, mianserin and trazodone. Comp Biochem Physiol 86C:225-232.
4. Browne RG, Koe BK. 1982. Clozapine and agents with similar behavioral and biochemical properties. In: Colpaert FC, Slangen JL. editors. Drug discrimination: applications in CNS pharmacology. Amsterdam: Elsevier Biomedical Press. p 241-254.
5. Carlsson A. 1978. Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 135:164-173.
6. Carlton PL, Manowitz P. 1984. Dopamine and schizophrenia: an analysis of the theory. Neurosci Biobehav Rev 8:137-151.
7. Carey GJ, Bergman J. 1997. Discriminative-stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs. Psychopharmacology 132:261-269
8. Casey E. 1989. Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology 99: S47-S53.
9. Claghorn J, Honigfeld G, Abuzzanab FS, Wang R, Steinbook R, Tauson V, Klerman G. 1987. The risks and benefits of clozapine versus chlorpromazine. Clin Psychopharmacol 7:377-384.
10. Comer SA, France CP, Woods JH. 1991. Training dose: influences in opioid drug discrimination. In: Glennon, RA, Jarbe TUC, Frankenheim J, editors. Drug discrimination: applications to drug abuse research. Research monograph 116. Rockville, MD: NIDA. p 145-161.
11. Cooper JR, Bloom FE, Roth RH. 1996. The biochemical basis of neuropharmacology. New York: Oxford University Press. p 92.
12. Crow T. 1987. Positive and negative symptoms in schizophrenia. In: Henn FA, DeLisi LE. editors. Neurochemistry and neuropharmacology of schizophrenia. New York: Elsevier Science Publishing, p 178-189.
13. Ellenbroek BA. 1993. Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs. Pharmacol Ther 57:1-78.
14. Extance K, Goudie A. 1981. Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology 73:363-371.
15. Franklin SR, Tang AH. 1994. Discriminative stimulus effects of clozapine in rats. Behav Pharmacol 5:113-114 (abstract).
16. Goas JA, Boston JE Jr. 1978. Discriminative stimulus properties of clozapine and chlorpromazine. Pharmacol Biochem Behav 8:235-241.
17. Golds PR, Przyslo FR, Strange PG. 1980. The binding of some antidepressant drugs to brain muscarinic acetylcholine receptors. Br J Pharmacol 68:541-549.
18. Goudie AJ, Taylor A. 1998. Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotic in rats. Psychopharmacology 135:392-400.
19. Goudie AJ, Taylor A, Smith JA. 1997. Clozapine drug discrimination in rats: a pharmacologically specific stimulus. Drug Dev Res 120:241P
20. Hoenicke EM, Vanecek SA, Woods JH. 1992. The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine-1c and 5-hydroxytryptamine-2 receptors. J Pharmacol Exp Ther 263:276-284.
21. Honigfeld G, Patin J, Singer J. 1984. Clozapine: antipsychotic activity in treatment-resistant schizophrenics. Adv Ther 1:77-97.
22. Hyttel J, Larsen JJ, Christensen AV, Arnt J. 1985. Receptor-binding profiles of neuroleptics. In: Casey DE, Chase TN, Christensen AV, Gerlach J, editors. Dyskinesia: research and treatment. New York: Springer-Verlag, p 9-18.
23. Jackson DM, Ryan C, Evenden J, Mohell N. 1994. Preclinical findings with new antipsychotic agents: what makes them atypical? Acta Psychiatr Scand 89:41-48.
24. Kane J, Honigfeld G, Singer J, Meltzer H. 1988. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison versus chlorpromazine/benztropine. Arch Gen Psychiatry 45:789-796.
25. Kelley BM, Porter JH. 1997. The role of muscarinic cholinergic receptors in the discriminative stimulus propertied of clozapine in rats. Pharmacol Biochem Behav 57:707-719.
26. Kelley BM, Nutti KA, Porter JH. 1994. Further evidence for muscarinic antagonism as the basis for clozapine's discriminative stimulus. Soc Neurosci Abstr 20:1637.
27. Kopera H. 1978. Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo. Br J Clin Pharmacol 5:29S-34S.
28. Lieberman JA, Saltz BL, Johns CA, Pollack S, Kane J. 1989. Clozapine effects on tardive dyskinesia. Psychopharmacol Bull 25:57-62.
29. Meltzer HY. 1989. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99:S18-S27.
30. Meltzer HY. 1992. The mechanism of action of clozapine in relation to its clinical advantages. In: Meltzer HY, editor. Novel antipsychotic drugs. New York: Raven Press. p 1-13.
31. Meltzer HY, Luchins DJ. 1984. Effects of clozapine in severe tardive dyskinesia: a case report. J Clin Psychopharmacol 4:316-322.
32. i values. J Pharmacol Exp Ther 251: 238-246.
33. Nielsen EB. 1988. Cholinergic mediation of the discriminative stimulus properties of clozapine. Psychopharmacology 94:115-118.
34. Ortmann R, Meisburger JG, Bischoff S, Hauser K, Bittiger H, Waldmeier PC. 1986. The clozapine cue in rats as tools for the characterization of neuroleptics. Psychopharmacology 89:S47 (abstract).
35. Peet M, Behagel H. 1978. Mianserin: a decade of scientific development. Br J Clin Pharmacol 5:5S-9S.
36. Pickar D. 1986. Neuroleptics, dopamine, and schizophrenia. Schizophrenia 9:35-48.
37. Richelson E, Nelson A. 1984. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. Eur J Pharmacol 103:197-204.
38. 4 receptors. Neuropsychopharmacology 16:93-110.
39. Shannon HE, Holtzman SG. 1979. Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat. Psychopharmacology 61:239-244.
40. Schmidt WJ, Volz TL. 1992. Clozapine-like discriminate stimulus effects of N-methyl-D-aspartate(NMDA). J Psychopharmacol Suppl Abstract: BAP & EBPS Joint Meeting, Cambridge.
41. Snyder SH, Banerjee SP, Yamamura HI, Greenberg D. 1974. Drugs, neurotransmitters, and schizophrenia. Science 184:1243-1253.
42. Tamminga CA. 1983. Atypical neuroleptics and novel antipsychotic drugs. In: Coyle JT, Enna JS, editors. Neuroleptics: Neurochemical, Behavioral, and Chemical Perspectives. New York: Raven Press. p 281-295.
43. Tandon R, Greden JF. 1989. Cholinergic hyperactivity and negative schizophrenic symptoms. Arch Gen Psychiatry 46:745-753.
44. Tang, AH, Franklin SR, Himes CS, Smith MW, Tenbrink RE. 1997. PNU-96415E, a potential antipsychotic agent with clozapine-like pharacological properties. J Pharmacol Exp Ther 281:440-447.
45. Villanueva HF, Arezo S, Rosecrans JA, Porter JH. 1990. Discriminative stimulus properties of clozapine. Soc Neurosci Abstr 16:248.
46. Wiley JL, Porter JH. 1992. Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure. Pharmacol Biochem Behav 43:961-965.
47. Wiley JL, Porter JH. 1993. Effects of serotonergic drugs in rats trained to discriminate clozapine from haloperidol. Bull Psychon Soc 31:94-96.
48. Young CR, Longhurst JG, Bowers MB Jr, Mazure CM. 1997. The expanding indications for clozapine. Exp Clin Psychopharmacol 5:216-234.